Stress CMR ischaemic burden and long-term mortality in left ventricular systolic dysfunction: a multicentre registry

Alexandre Pfeffer1,2,3,4,5, Jérôme Garot3,5,6, Suzanne Duhamel5,6

  • 1Université Paris Cité, Department of Cardiology, University Hospital of Lariboisiere, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris 75010, France.

Insights

Stress perfusion cardiovascular magnetic resonance (CMR) identifies myocardial ischemia, which independently predicts long-term mortality in patients with reduced left ventricular ejection fraction (LVEF). Integrating ischemia and scar imaging improves risk stratification for LV systolic dysfunction.

Area of Science:

  • Cardiovascular Imaging
  • Cardiac MRI
  • Myocardial Perfusion Imaging

Background:

  • Stress perfusion cardiovascular magnetic resonance (CMR) assesses myocardial ischemia, scar, and function.
  • Its prognostic value in patients with left ventricular (LV) systolic dysfunction is not fully established.

Purpose of the Study:

  • To evaluate the incremental prognostic value of inducible ischemia and late gadolinium enhancement (LGE) on stress perfusion CMR.
  • To assess these markers in patients with LV systolic dysfunction (LVEF <50%).

Main Methods:

  • Analysis of a prospective multicenter registry of 5,977 patients with LVEF <50% undergoing vasodilator stress perfusion CMR.
  • Multivariable Cox models and reclassification metrics (NRI, IDI) assessed associations with all-cause mortality over 9 years.
  • Evaluated incremental prognostic value beyond clinical factors and LVEF.

Main Results:

  • Inducible ischemia was present in 19% of patients; ischemic segment extent independently predicted mortality (HR 1.11 per segment).
  • Adding ischemia and LGE to clinical factors and LVEF significantly improved model fit and reclassification (p<0.001).
  • Findings were consistent across LVEF subgroups (<40% and 40-50%).

Conclusions:

  • Ischemic burden on stress-CMR is an independent predictor of long-term mortality in patients with LVEF <50%.
  • Integrating ischemia and scar metrics provides incremental prognostic information for risk stratification.
  • Stress-CMR aids risk stratification in LV systolic dysfunction.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...